Amira Pharmaceuticals, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 70
Rang # Quantité totale PI 19 140
Note d'activité PI 0/5.0    0
Rang # Activité PI 1 653 802
Parent Bristol-myers Squibb Company

Brevets

Marques

18 0
0 0
52 0
0
 
Dernier brevet 2017 - Polycyclic lpa1 antagonist and u...
Premier brevet 2006 - 5-lipoxygenase-activating protei...

Derniers inventions, produits et services

2016 Invention Polycyclic lpa1 antagonist and uses thereof. Described herein is the LPA1 antagonist 1-{4′-[3-me...
2015 Invention Compounds as lysophosphatidic acid receptor antagonists. Described herein are compounds that are ...
Invention Autotaxin inhibitors and uses thereof. Described herein are compounds that are inhibitors of auto...
2014 Invention Polycyclic compounds as lysophosphatidic acid receptor antagonists. Described herein are compound...
2012 Invention Heterocyclic autotaxin inhibitors and uses thereof. Described herein are compounds that are inhib...
Invention Lysophosphatidic acid receptor antagonists. Described herein are compounds that are antagonists o...
Invention 3- or 5 - bi phenyl - 4 - ylisoxazole - based compounds useful for the treatment of fibrosis, pai...
2011 Invention Polycyclic lpa1 antagonist and uses thereof. Described herein is the LPA1 antagonist 1-{4′-[3-met...
Invention Polycyclic lpa1 antagonist and uses thereof. Described herein is the LPA1 antagonist 1- {4'-[3-me...
Invention Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis. Described her...
Invention Lysophosphatidic acid receptor antagonists and uses thereof. Described herein are compounds that ...
Invention Polycyclic antagonists of lysophosphatidic acid receptors. Described herein are compounds that ar...
Invention Lysophosphatidic acid receptor antagonists for the treatment of conditions or diseases of the eye...
Invention Inhalable formulations of lysophosphatidic acid receptor antagonists. Described herein are inhala...
Invention Lysophosphatidic acid receptor antagonist for the treatment of dermal conditions. Described herei...
Invention Lysophosphatidic acid receptor antagonist and uses thereof. Described herein is the LPAl antagoni...
Invention Antagonists of lysophosphatidic acid receptors. Described herein are compounds that are antagonis...
2010 Invention Tricyclic compounds as antagonists of prostaglandin d2 receptors. Described herein are antagonist...
2009 Invention Topical formulations of flap inhibitors for the treatment of dermatological conditions. Describe...
Invention Topical formulations of flap inhibitors for administration to an eye. Described herein are topica...
Invention Topical formulations of flap inhibitors for the treatment of dermatological conditions. Described...
Invention Antagonists of lysophosphatidic acid receptors. Described herein are compounds that are antagoni...
Invention Alkyne antagonists of lysophosphatidic acid receptors. Described herein are compounds that are an...